Strategic Partnerships VHIO's translational research model and close integration with Vall d’Hebron University Hospital create a fertile environment for collaborative clinical trials and joint development programs. Potential sales opportunities include co-development agreements, sponsored research, and access to VHIO’s patient networks for first-in-class diagnostics or therapeutics.

Precision Oncology VHIO emphasizes precision oncology and combating resistance across heterogeneous tumors. Opportunities exist to offer targeted therapies, companion diagnostics, and genomics-driven treatment platforms aligned with VHIO’s Cancer Genomics Laboratory and computational immunogenomics capabilities.

Innovation & Recognition Recent accolades such as Severo Ochoa Centre of Excellence and notable awards for early-career researchers highlight VHIO’s prestige and growing capabilities. Use this to position high-value collaborations, grant-aligned projects, and technology licensing discussions with VHIO leadership.

Data & Tech Stack VHIO leverages cloud and analytics tools (AWS, Cognos, Power BI, GitHub, Docker) to power research and translational workflows. Potential sales angles include scalable data platforms, secure bioinformatics pipelines, and AI-driven analytics services for genomic and Clinical data integration.

Funding & Scale Operating with a mid-market revenue profile and substantial research activity, VHIO is a credible partner for multi-institutional studies, grant-supported projects, and sponsored trials. Align outreach around large-scale collaboration opportunities, technology licensing, and service contracting that fit a center of excellence.